Financhill
Back

BridgeBio Pharma Stock Predictions

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 36.5% based on the past 4 years of stock performance.
  • BridgeBio Pharma has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $25.00. The Score for BBIO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 36.5% based on the past 4 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
35
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
44.32
52-Week Low:
16.61

Prediction Charts

Market Cap:
4.68B
Price in USD:
25.00
Volume:
1.02M
Beta:
1.06

Technical Analysis

SMA50:
27.27
SMA100:
28.81
SMA200:
30.19
52-Wk Change:
44.09%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 25.00 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 28.58 29.03 29.34 28.42
Jun-14 28.43 27.86 28.55 27.47
Jun-17 27.79 27.23 28.26 27.11
Jun-18 27.26 27.61 27.76 26.23
Jun-20 27.36 27.05 27.59 26.89
Jun-21 26.99 27.33 27.47 26.50
Jun-24 24.28 23.00 24.72 21.62
Jun-25 23.17 23.39 24.13 22.39
Jun-26 23.26 23.56 24.40 23.11
Jun-27 23.55 25.20 25.26 23.22
Jun-28 25.48 25.41 26.00 24.66
Jul-1 25.50 25.20 26.10 24.99
Jul-2 25.20 24.91 25.71 24.90
Jul-3 25.02 25.00 25.48 24.71

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.30 per share, an increase this year of $2.47 per share, and a decrease next year of $2.17 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.